oncology portfolio - Robuta Search

https://www.labmedica.com/caredx-expands-precision-oncology-portfolio-with-naveris-acquisition/articles/294810098/caredx-expands-precision-oncology-portfolio-with-naveris-acquisition.html CareDx Expands Precision Oncology Portfolio with Naveris Acquisition - Industry News - Labmedica.com CareDx Expands Precision Oncology Portfolio with Naveris Acquisition precision oncology industry news caredx expands portfolio https://jobs.vertexventureshc.com/companies/eyebio/jobs/74283713-senior-oncology-portfolio-manager Senior Oncology Portfolio Manager @ EyeBio | Vertex Ventures HC Job Board Search job openings across the Vertex Ventures HC network. oncology portfolio job board senior manager vertex https://www.biontech.com/int/en/home/mediaroom/news/press-releases/2024/09/biontech-present-clinical-data-updates-across-mrna-and.html BioNTech to Present Clinical Data Updates Across mRNA and Immunomodulatory Oncology Portfolio at... to present clinical data oncology portfolio biontech updates https://pressreleasehub.pa.media/article/incyte-to-showcase-new-data-from-its-oncology-portfolio-at-2025-american-society-of-clinical-oncology-asco-annual-meeting-43775.html Incyte to Showcase New Data from its Oncology Portfolio at 2025 American Society of Clinical... Incyte to Showcase New Data from its Oncology Portfolio at 2025 American Society of Clinical Oncology (ASCO) Annual Meeting new data oncology portfolio american society incyte showcase https://www.fitchsolutions.com/bmi/segments-corporates/merck-bolsters-oncology-portfolio-usd290mn-orion-deal-19-07-2022 Merck Bolsters Oncology Portfolio With USD290mn Orion Deal Merck bolsters its oncology pipeline with latest licencing agreement with Orion. The two companies will co-develop and co-commercialise an experimental prostat oncology portfolio merck bolsters orion deal https://www.koreanewswire.co.kr/newsRead.php?no=989748 Takeda to Present Oncology Portfolio and Pipeline Data at the 2024 ASCO Annual Meeting - Korea... asco annual meeting to present oncology portfolio pipeline data takeda https://www.biospace.com/fresenius-kabi-further-expands-oncology-portfolio-with-launch-of-cyclophosphamide-for-injection-usp Fresenius Kabi Further Expands Oncology Portfolio with Launch of Cyclophosphamide for Injection,... Feb 28, 2024 - Fresenius Kabi announced today it has introduced Cyclophosphamide for Injection, USP, a generic substitute for Cytoxan, for use in treating several forms of... fresenius kabi oncology portfolio expands launch cyclophosphamide https://www.indiainfoline.com/news/companies/biocon-unit-expands-oncology-portfolio-after-usfda-approval Biocon unit expands oncology portfolio after USFDA approval | India Infoline Jobevne is a vascular endothelial growth factor (VEGF) impediment that sticks with VEGF and restrain the interaction with its receptors. oncology portfolio biocon unit expands usfda https://www.worldpharmatoday.com/press-releases/astrazeneca-oncology-portfolio-strengthened-as-medimmune-acquisition-of-spirogen-boosts-antibody-drug-conjugate-capability-2/ AstraZeneca oncology portfolio strengthened as MedImmune acquisition of Spirogen boosts... Oct 31, 2013 - AstraZeneca today announced that MedImmune, its global biologics research and development arm, has acquired Spirogen, a privately-held biotech company focused... oncology portfolio astrazeneca strengthened acquisition boosts https://inizio.com/our-businesses/ignite/insights/designing-a-new-gtm-model-for-an-ambitious-upcoming-oncology-launch/ Designing a portfolio wide GTM model to support upcoming oncology launch - Inizio Jan 2, 2026 - A global pharma client looking to design a new GtM model for an ambitious upcoming oncology launch, enlisted Putnam's expertise. designing portfolio wide gtm model